SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001544784-24-000027
Filing Date
2024-05-07
Accepted
2024-05-07 16:01:01
Documents
109
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q gdnsf-20240331x10q.htm   iXBRL 10-Q 1346855
2 EX-10.66 gdnsf-20240331xex10d66.htm EX-10.66 51125
3 EX-10.67 gdnsf-20240331xex10d67.htm EX-10.67 73838
4 EX-31.1 gdnsf-20240331xex31d1.htm EX-31.1 17156
5 EX-31.2 gdnsf-20240331xex31d2.htm EX-31.2 16627
6 EX-32.1 gdnsf-20240331xex32d1.htm EX-32.1 8865
  Complete submission text file 0001544784-24-000027.txt   8173956

Data Files

Seq Description Document Type Size
7 EX-101.SCH gdnsf-20240331.xsd EX-101.SCH 78663
8 EX-101.CAL gdnsf-20240331_cal.xml EX-101.CAL 76332
9 EX-101.DEF gdnsf-20240331_def.xml EX-101.DEF 272211
10 EX-101.LAB gdnsf-20240331_lab.xml EX-101.LAB 594412
11 EX-101.PRE gdnsf-20240331_pre.xml EX-101.PRE 479785
113 EXTRACTED XBRL INSTANCE DOCUMENT gdnsf-20240331x10q_htm.xml XML 1372961
Mailing Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402
Business Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402 604-617-5421
Goodness Growth Holdings, Inc. (Filer) CIK: 0001771706 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56225 | Film No.: 24921633
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)